Cargando…
Nivolumab‐induced sialadenitis
Nivolumab has been increasingly used for a range of malignancies, and a variety of immune‐related adverse events (irAEs) have been reported with its use. Nivolumab‐induced sialadenitis (inflammation of salivary glands) and xerostomia (dry mouth) have been reported to occur in 0.03% and 0.05% respect...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Ltd
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899999/ https://www.ncbi.nlm.nih.gov/pubmed/29686875 http://dx.doi.org/10.1002/rcr2.322 |